Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1085 (17 May), doi:10.1136/bmj.39577.425544.3A
| The first 150 words of the full text of this article appear below. |
Treloar misunderstands the fundamental premise of the Liverpool care pathway (LCP).1 A patient is put on the pathway only once it is recognised they are dying imminently, within hours to a few days.2 The evidence does not support that artificial hydration or nutrition has a role to ease symptoms and suffering and may, in fact, add to it.3
Deep sedation is not recommended as part of the Liverpool care pathway and is not usual practice in UK palliative care teaching. Sedation can be a feature of symptom management but is not the prime aim. Morphine will be used to treat pain or breathlessness, glycopyrronium to treat bubbly secretions, haloperidol to treat nausea or agitation and delirium, midazolam to treat distress, etc. Most patients do not need large doses of these medications to achieve the necessary symptom control. In a study from St Christophers Hospice, dose increases in sedative medication at
Lulu Kreeger, consultant palliative medicine
1 Kingston Hospital NHS Trust and Princess Alice Hospice, Esher KT10 8NA
luluk@globalnet.co.uk